# PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers

> **NCT04941781** · PHASE1 · COMPLETED · sponsor: **Contineum Therapeutics** · enrollment: 6 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** PIPE-307

## Key facts

- **NCT ID:** NCT04941781
- **Lead sponsor:** Contineum Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2021-11-10
- **Final completion:** 2021-11-10
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941781, "PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04941781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*